Management of Mild Basal Atelectasis Following Influenza-Like Illness

Initial Assessment and Monitoring

The British Thoracic Society recommends calculating the CURB-65 score to stratify pneumonia risk in patients with mild basal atelectasis following influenza-like illness 3, 2
The American Thoracic Society suggests measuring oxygen saturation via pulse oximetry and obtaining arterial blood gases if saturation is less than 92% on room air 3, 4
The European Respiratory Society advises checking vital signs, including temperature, respiratory rate, pulse, blood pressure, and mental status, in patients with mild basal atelectasis 1, 2
Basic laboratory work, such as complete blood count, urea and electrolytes, and C-reactive protein, should be performed in patients with mild basal atelectasis 3, 4

The British Thoracic Society recommends implementing chest physiotherapy and postural drainage to mobilize secretions and re-expand atelectatic lung segments in stable patients with mild basal atelectasis 1, 5
The American College of Chest Physicians suggests monitoring vital signs at least twice daily using an Early Warning Score system in patients with mild basal atelectasis 1, 5
No routine microbiological testing is needed for non-severe cases of mild basal atelectasis once a pandemic is established, according to the World Health Organization 1, 3

The Centers for Disease Control and Prevention recommend considering antiviral treatment with oseltamivir in patients with acute influenza-like illness, fever greater than 38°C, and symptom onset within 2 days 6, 7, 2
The dosage of oseltamivir is 75 mg orally twice daily for 5 days, with a reduced dose of 75 mg once daily if creatinine clearance is less than 30 mL/min, as recommended by the Infectious Diseases Society of America 6, 7, 2

The British Thoracic Society advises against routine use of antibiotics in patients with mild atelectasis without evidence of bacterial superinfection 1, 3
The American Thoracic Society recommends starting empiric antibiotics only if the CURB-65 score is 3 or higher, or if there are clinical signs of bacterial infection, such as purulent sputum or elevated white blood cell count 1, 3, 2
The European Respiratory Society suggests using oral amoxicillin or doxycycline for non-severe pneumonia and intravenous co-amoxiclav or second/third generation cephalosporin for severe pneumonia 2, 4

The American College of Chest Physicians recommends monitoring temperature, respiratory rate, pulse, blood pressure, mental status, and oxygen saturation at least twice daily in patients with mild basal atelectasis 1, 5, 2
The British Thoracic Society advises reassessing patients who do not show clinical improvement within 48 hours and considering hospitalization if there are signs of clinical instability 1, 5

The American Thoracic Society recommends initiating supplemental oxygen to maintain PaO₂ greater than 8 kPa and SaO₂ greater than or equal to 92% in patients with mild basal atelectasis and oxygen saturation less than 92% on room air 1, 6, 5, 2
The European Respiratory Society suggests guiding oxygen therapy by repeated arterial blood gas measurements in patients with pre-existing COPD 1, 5

The British Thoracic Society recommends managing most patients with mild basal atelectasis and stable vital signs as outpatients with close follow-up 1, 3
The American College of Chest Physicians advises admitting patients to the hospital if they have a CURB-65 score of 3 or higher, oxygen saturation less than 92% on room air, or two or more clinical instability criteria present 3, 2